Michael J. Beckman

1.3k total citations · 1 hit paper
20 papers, 924 citations indexed

About

Michael J. Beckman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Michael J. Beckman has authored 20 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Michael J. Beckman's work include Pancreatic and Hepatic Oncology Research (8 papers), Gastrointestinal Tumor Research and Treatment (5 papers) and Pancreatitis Pathology and Treatment (3 papers). Michael J. Beckman is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Gastrointestinal Tumor Research and Treatment (5 papers) and Pancreatitis Pathology and Treatment (3 papers). Michael J. Beckman collaborates with scholars based in United States, Israel and Canada. Michael J. Beckman's co-authors include Fabian M. Johnston, Ronald P. DeMatteo, Daniela Amital, Б. Спивак, Leah Fostick, Adrian M. Seifert, Shan Zeng, Ferdinand Rossi, Cristina R. Antonescu and Megan H. Crawley and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Michael J. Beckman

20 papers receiving 907 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Updates on Management of Gastric Cancer

2019 348 citations Fabian M. Johnston, Michael J. Beckman Current Oncology Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael J. Beckman United States	13	312	291	248	170	165	20	924
Giulia Vita Italy	18	240 0.8×	255 0.9×	296 1.2×	150 0.9×	111 0.7×	46	1.2k
Ulrike Haus Germany	18	177 0.6×	269 0.9×	216 0.9×	35 0.2×	91 0.6×	31	955
Ju‐Yeon Kim South Korea	20	174 0.6×	279 1.0×	420 1.7×	266 1.6×	267 1.6×	64	1.3k
Roopma Wadhwa United States	15	494 1.6×	323 1.1×	471 1.9×	206 1.2×	459 2.8×	40	1.4k
Shiqing Chen China	12	258 0.8×	490 1.7×	218 0.9×	119 0.7×	101 0.6×	66	860
Maryam Abolhasani Iran	20	250 0.8×	327 1.1×	517 2.1×	228 1.3×	145 0.9×	100	1.1k
Satoshi Hase Japan	16	348 1.1×	274 0.9×	61 0.2×	43 0.3×	490 3.0×	40	789
Li Gao China	20	87 0.3×	121 0.4×	596 2.4×	214 1.3×	51 0.3×	65	1.2k
Isabel Álvarez Spain	14	183 0.6×	267 0.9×	137 0.6×	179 1.1×	115 0.7×	60	652
Liang Han China	18	72 0.2×	388 1.3×	394 1.6×	192 1.1×	173 1.0×	36	888

Countries citing papers authored by Michael J. Beckman

Since Specialization

Citations

This map shows the geographic impact of Michael J. Beckman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Beckman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Beckman more than expected).

Fields of papers citing papers by Michael J. Beckman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Beckman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Beckman. The network helps show where Michael J. Beckman may publish in the future.

Co-authorship network of co-authors of Michael J. Beckman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Beckman. A scholar is included among the top collaborators of Michael J. Beckman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Beckman. Michael J. Beckman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cochran, Allyson, et al.. (2023). 10 years, 100 robotic major hepatectomies: a single-center experience. Surgical Endoscopy. 38(2). 902–907. 6 indexed citations

Yoshino, Osamu, Philip C. Müller, Huaping Wang, et al.. (2023). Expanding the utility of robotics for pancreaticoduodenectomy: a 10-year review and comparison to international benchmarks in pancreatic surgery. Surgical Endoscopy. 37(12). 9591–9600. 8 indexed citations

Davis, Joshua M., et al.. (2023). External validation of the Japanese difficulty score for laparoscopic hepatectomy in patients undergoing robotic-assisted hepatectomy. Surgical Endoscopy. 37(9). 7288–7294. 5 indexed citations

Wang, Yifan, et al.. (2023). Robotic pancreatic necrosectomy and internal drainage for walled-off pancreatic necrosis. HPB. 25(7). 813–819. 2 indexed citations

Hue, Jonathan J., Mohamedraed Elshami, Michael J. Beckman, et al.. (2021). A Propensity-Matched Analysis of the Postoperative Venous Thromboembolism Rate After Pancreatoduodenectomy Based on Operative Approach. Journal of Gastrointestinal Surgery. 26(3). 623–634. 6 indexed citations

Watson, Michael, Jennifer L. Miller-Ocuin, Michael J. Beckman, et al.. (2020). Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database. SHILAP Revista de lepidopterología. 6(1). 85–95. 22 indexed citations

Schmocker, Ryan K., Michael Wright, Ding Ding, et al.. (2020). An Aggressive Approach to Locally Confined Pancreatic Cancer: Defining Surgical and Oncologic Outcomes Unique to Pancreatectomy with Celiac Axis Resection (DP-CAR). Annals of Surgical Oncology. 28(6). 3125–3134. 25 indexed citations

Pu, Ning, Shanshan Gao, Ross M. Beckman, et al.. (2020). Defining a minimum number of examined lymph nodes improves the prognostic value of lymphadenectomy in pancreas ductal adenocarcinoma. HPB. 23(4). 575–586. 12 indexed citations

Santamaria‐Barria, Juan A., Shan Zeng, Jonathan B. Greer, et al.. (2019). Csf1r or Mer inhibition delays liver regeneration via suppression of Kupffer cells. PLoS ONE. 14(5). e0216275–e0216275. 12 indexed citations

10.

Johnston, Fabian M. & Michael J. Beckman. (2019). Updates on Management of Gastric Cancer. Current Oncology Reports. 21(8). 67–67. 348 indexed citations breakdown →

11.

Beckman, Michael J., et al.. (2019). Navigating difficult conversations. Journal of Surgical Oncology. 120(1). 23–29. 13 indexed citations

12.

Zhang, Jennifer Q., Shan Zeng, Gerardo A. Vitiello, et al.. (2018). Macrophages and CD8+ T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors. Cancer Immunology Research. 6(4). 434–447. 48 indexed citations

13.

Zeng, Shan, Adrian M. Seifert, Jennifer Q. Zhang, et al.. (2017). Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor. Molecular Cancer Therapeutics. 16(9). 1954–1966. 31 indexed citations

14.

Seifert, Adrian M., Shan Zeng, Jennifer Q. Zhang, et al.. (2016). PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors. Clinical Cancer Research. 23(2). 454–465. 117 indexed citations

15.

Cohen, Noah A., Shan Zeng, Adrian M. Seifert, et al.. (2015). Pharmacological Inhibition of KIT Activates MET Signaling in Gastrointestinal Stromal Tumors. Cancer Research. 75(10). 2061–2070. 46 indexed citations

16.

Patwardhan, Parag P., Oliver Surriga, Michael J. Beckman, et al.. (2014). Sustained Inhibition of Receptor Tyrosine Kinases and Macrophage Depletion by PLX3397 and Rapamycin as a Potential New Approach for the Treatment of MPNSTs. Clinical Cancer Research. 20(12). 3146–3158. 94 indexed citations

17.

Seifert, Adrian M., Teresa S. Kim, Jonathan B. Greer, et al.. (2014). PD-1/PD-L1 Blockade Enhances the Efficacy of Imatinib in Gastrointestinal Stromal Tumor (GIST). Journal of the American College of Surgeons. 219(3). S129–S129. 2 indexed citations

18.

Fostick, Leah, et al.. (2010). The economic impact of depression: Resistance or severity?. European Neuropsychopharmacology. 20(10). 671–675. 45 indexed citations

19.

Amital, Daniela, et al.. (2008). Serious life events among resistant and non-resistant MDD patients. Journal of Affective Disorders. 110(3). 260–264. 66 indexed citations

20.

Beckman, Michael J.. (2007). More Clinical Cancer Treatments Judged by Progression-Free Rather Than Overall Survival. JNCI Journal of the National Cancer Institute. 99(14). 1068–1069. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact